A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis

Phase 1 Completed 42 enrolled Janssen Research & Development, LLC

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of JNJ-64251330 in participants with Familial Adenomatous Polyposis (FAP) on colorectal polyp burden (sum of the polyp diameters).

Timeline

Start: 2021-11-10
Primary completion: 2023-02-15
Completion: 2023-02-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	JNJ-64251330	Small molecule	—	Oral

A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis

Summary

Timeline

Drugs

Indications